Please Note: This trial is no longer enrolling new participants
Phase I trial of a chimeric (trastuzumab-like and pertuzumab-like) HER2 B cell peptide vaccine emulsified in ISA 720 adjuvant for locally advanced HER2 positive breast cancer
| Protocol No. | CTO-IUSCCC-0864 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Pravin Kaumaya | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
